Danaher Raises 2026 Adjusted EPS Guidance, Q3 Revenue Grows 8.5%

Danaher (DHR) raised its full-year 2026 adjusted diluted net earnings per share guidance to a range of $8.57 to $8.62, up from a prior range of $8.45 to $8.60. Shares rose 0.44% to $225.00 in pre-market trading on the NYSE. For the fourth quarter, the company expects non-GAAP core revenue excluding respiratory revenue to grow 4.0% to 5.0% year-over-year. Respiratory revenue is expected to be an approximately 150 basis point headwind, resulting in core revenue growth of approximately 3.0%. Third quarter net earnings were $1.2 billion, or $1.71 per diluted share, up 34.5% year-over-year. Non-GAAP adjusted diluted EPS grew 11.5% to $2.11, while revenues increased 8.5% to $6.6 billion. Non-GAAP core revenue excluding respiratory revenue rose 5.5%, and non-GAAP core revenue increased 3.0%.